16:20 EDT Clene (CLNN) files to sell 491,496 shares of common stock for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLNN:
- Clene’s CNM-Au8 Shows Promise in Parkinson’s Treatment, Justifying Buy Rating
- Clene presents preclinical data supporting CNM-Au8 for Parkinson’s disease
- Clene price target lowered to $48 from $83 at Canaccord
- Clene Inc. Reports Q2 2025 Financial Results
- Optimistic Buy Rating for Clene Amidst Regulatory Progress and Strategic Milestones in ALS Treatment